세계의 의약품 여과 시장 예측(2025-2030년)

The global pharmaceutical filtration market is projected to grow at a CAGR of 8.50% to be worth US$21.24 billion in 2030 from US$14.64 billion in 2025.

Growing demand for protein-based drugs because of the rising prevalence of inflammatory, infectious, and cardiovascular diseases across the globe is expected to drive the pharmaceutical filtration market growth during the forecast period. Moreover, increasing emphasis on biologics for the development of treatment of various diseases is a major factor contributing to the overall market growth.

Market Trends:

• The increasing prevalence of chronic diseases is expected to drive demand for pharmaceutical filtration.

A key factor supporting the growth of the pharmaceutical filtration market is the rising incidence of chronic conditions such as diabetes, asthma, cancer, and autoimmune diseases. The growing number of chronic disease cases has led to a higher demand for advanced therapeutic drugs worldwide. According to the World Health Organization, cancer is one of the leading causes of death globally, accounting for nearly 10 million deaths in 2020.

• Increased investments in biologics R&D

Another significant driver of the pharmaceutical filtration market is the rising investment in the research and development of biologics. The adoption of innovative treatment therapies, such as monoclonal antibodies, recombinant DNA (R-DNA) technology, therapeutic proteins, and vaccines, has spurred growth in biotechnology and pharmaceutical companies. These companies rely on filtration techniques, including membranes, capsules, and cartridges, to support their operations.

Pharmaceutical Filtration Market Geographical Outlook:

• North America and the Asia Pacific are expected to dominate the global pharmaceutical filtration market during the forecast period.

Geographically, the pharmaceutical filtration market is segmented into North America, Europe, Asia Pacific, South America, and the Middle East & Africa. North America is anticipated to lead the market, driven by the growing biopharmaceutical industry and advancements in manufacturing facilities. Meanwhile, the Asia Pacific region is projected to be the fastest-growing market, fueled by a large patient population with chronic diseases and increasing vaccine production in countries like China and India. These factors are significantly contributing to the expansion of the global pharmaceutical filtration market.

Some of the major players covered in this report include 3M, Danaher Corporation, GE Healthcare, GEA Group, Graver Technologies, Merck Millipore, Parker Hannifin Corporation, Repligen Corporation, Sartorius Stedim Biotech, Thermo Fisher Scientific among others.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Pharmaceutical Filtration Market Segmentations:

Pharmaceutical Filtration Market Segmentation by filtration type:

• The market is analyzed by filtration type into the following:
• Centrifugal
• Gravity
• Vacuum
• Others

Pharmaceutical filtration market Segmentation by technology:

• The report analyzes the market by technology as below:
• Cross Filtration
• Micro-Filtration
• Ultra-Filtration
• Others

Pharmaceutical filtration market Segmentation by application:

• The market is analyzed by application into the following:
• Water Separation
• Raw Material Filtration
• Product Filtration
• Others

Pharmaceutical filtration market Segmentation by end-user segment:

• The report analyzes the market by end-user segment as below:
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Manufacturing Organizations (CMOs)
• Research Institutions & Universities
• Hospitals and Clinics

Pharmaceutical filtration market Segmentation by regions:

The study also analyzed the pharmaceutical filtration market into the following regions, with country-level forecasts and analysis as below:

• North America (US, Canada, and Mexico)
• South America (Brazil, Argentina, and Others)
• Europe (Germany, UK, France, Spain and Others
• Middle East and Africa (Saudi Arabia, UAE and Others)
• Asia Pacific (China, Japan, India, South Korea, Thailand, Indonesia, and Others)

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PHARMACEUTICAL FILTRATION MARKET BY FILTRATION TYPE

• 5.1. Introduction
• 5.2. Centrifugal
• 5.3. Gravity
• 5.4. Vacuum
• 5.5. Others

6. PHARMACEUTICAL FILTRATION MARKET BY TECHNOLOGY

• 6.1. Introduction
• 6.2. Cross Filtration
• 6.3. Micro-Filtration
• 6.4. Ultra-Filtration
• 6.5. Others

7. PHARMACEUTICAL FILTRATION MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Water Separation
• 7.3. Raw Material Filtration
• 7.4. Product Filtration
• 7.5. Others

8. PHARMACEUTICAL FILTRATION MARKET BY END-USER INDUSTRY

• 8.1. Introduction
• 8.2. Pharmaceutical Companies
• 8.3. Biotechnology Companies
• 8.4. Contract Manufacturing Organizations (CMOs)
• 8.5. Research Institutions & Universities
• 8.6. Hospitals and Clinics

9. PHARMACEUTICAL FILTRATION MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. United Kingdom
  • 9.4.2. Germany
  • 9.4.3. France
  • 9.4.4. Italy
  • 9.4.5. Spain
  • 9.4.6. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. Japan
  • 9.6.3. India
  • 9.6.4. South Korea
  • 9.6.5. Taiwan
  • 9.6.6. Thailand
  • 9.6.7. Indonesia
  • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. 3M
• 11.2. Danaher Corporation
• 11.3. GE Healthcare
• 11.4. GEA Group
• 11.5. Graver Technologies
• 11.6. Merck Millipore
• 11.7. Parker Hannifin Corporation
• 11.8. Repligen Corporation
• 11.9. Sartorius Stedim Biotech
• 11.10. Thermo Fisher Scientific

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations